XML 47 R5.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash flows from operating activities    
Net loss $ (2,817,454) $ (2,136,962)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 43,893 33,240
Loss on sale of investment 287,513
Stock-based compensation 356,809 23,401
Other non-cash income and expenses (4,022)
Loss on investment in equity securities 182,113 164,649
Deferred tax (52,638) (242,092)
Changes in assets and liabilities:    
Decrease (increase) in accounts receivable (102,527) 685
Decrease (increase) in prepaid expenses and deposits 23,965 (79,172)
Decrease (increase) in due from related parties (283,831) 30,600
Decrease (increase) in inventory 1,298 11,293
Increase (decrease) in accounts payable 2,838
Increase (decrease) in notes payable (14,490)
Increase (decrease) in accrued expenses and other current liabilities 572,969 560,478
Increase (decrease) in advance from others 376,639
Increase (decrease) in due to related parties 75,729 178,067
Net cash used in operating activities (1,638,709) (1,168,300)
Cash flows from investing activities    
Net proceeds from sale of investment in equity securities 314,294
Loan to related parties (17,388)
Long-term equity investment (17,691)
Net cash provided by (used in) investing activities (35,079) 314,294
Cash flows from financing activities    
Issuance of common stock for acquisition 531,147
Proceeds from convertible notes 957,500 550,000
Proceeds from short-term bank loans 1,000,000
Proceeds from short-term borrowing from third-parties 846,300 132,264
Borrowings from related parties 141,850
Repayment of borrowings from related parties (820,000) (157,000)
Repayment of long-term bank loans (31,703)
Net cash provided by financing activities 2,483,244 667,114
Effect of exchange rate changes on cash and cash equivalents (437) (3,285)
Net increase (decrease) in cash, cash equivalents, and restricted cash equivalents 809,019 (190,177)
Cash, cash equivalents, and restricted cash equivalents    
Beginning 242,781 406,836
Ending 1,051,800 216,659
Cash paid during the year for:    
Income tax 2,050 1,850
Interest expense 103,099 114,409
Non-cash financing and investing activities    
Common shares issued for employees and consultants $ 80,000